Cabbage Juices and Indoles Modulate the Expression Profile of AhR, ERα, and Nrf2 in Human Breast Cell Lines

REFERENCES

• Okino ST, Pookot D, Basak S, and Dahiya R: Toxic and chemopreventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways: implications for cancer prevention. Cancer Prev Res (Phila) 2, 251–256, 2009.
   PubMed Web of Science ®Google Scholar
• Ashida H, Nishiumi S, and Fukuda I: An update on the dietary ligands of the AhR. Expert Opin Drug Metab Toxicol 4, 1429–1447, 2008.
   PubMed Web of Science ®Google Scholar
• Köhle C, and Bock KW: Activation of coupled Ah receptor and Nrf2 gene batteries by dietary phytochemicals in relation to chemoprevention. Biochem Pharmacol 72, 795–805, 2006.
   Google Scholar
• Singhal R, Shankar K, Badger TM, and Ronis MJ: Estrogenic status modulates aryl hydrocarbon receptor-mediated hepatic gene expression and carcinogenicity. Carcinogenesis 29, 227–236, 2008.
   Google Scholar
• Ansell PJ, Lo SC, Newton LG, Espinosa-Nicholas C, Zhang DD, et al.: Repression of cancer protective genes by 17beta-estradiol: ligand-dependent interaction between human Nrf2 and estrogen receptor alpha. Mol Cell Endocrinol 243, 27–34, 2005.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Dinkova-Kostova AT, and McMahon M: Cross-talk between transcription factors AhR and Nrf2: lessons for cancer chemoprevention from dioxin. Toxicol Sci 111, 199–201, 2009.
   PubMed Web of Science ®Google Scholar
• Yeager RL, Reisman SA, Aleksunes LM, and Klaassen CD: Introducing the “TCDD-inducible AhR-Nrf2 gene battery”. Toxicol Sci 111, 238–246, 2009.
   PubMed Web of Science ®Google Scholar
• Lo R, and Matthews J: The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells. Toxicol Appl Pharmacol 270, 139–148, 2013.
   PubMed Web of Science ®Google Scholar
• Yao Y, Brodie AM, Davidson NE, Kensler TW, and Zhou Q: Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer. Breast Cancer Res Treat 124, 585–591, 2010.
   PubMed Web of Science ®Google Scholar
• Szaefer H, Licznerska B, Krajka-Kuźniak V, Bartoszek A, and Baer-Dubowska W: Modulation of CYP1A1, CYP1A2 and CYP1B1 expression by cabbage juices and indoles in human breast cell lines. Nutr Cancer 64, 879–888, 2012.
   PubMed Web of Science ®Google Scholar
• Mulvey L, Chandrasekaran A, Liu K, Lombardi S, Wang XP, et al.: Interplay of genes regulated by estrogen and diindolylmethane in breast cancer cell lines. Mol Med 13, 69–78, 2007.
   PubMed Web of Science ®Google Scholar
• Jin L, Qi M, Chen DZ, Anderson A, Yang GY, et al.: Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Res 59, 3991–3997, 1999.
   PubMed Web of Science ®Google Scholar
• Bell MC, Crowley-Nowick P, Bradlow HL, Sepkovic DW, Schmidt-Grimminger D, et al.: Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 78, 123–129, 2000.
   PubMed Web of Science ®Google Scholar
• Bradlow HL, Michnovicz J, Telang NT, and Osborne MP: Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12, 1571–1574, 1991.
   PubMed Web of Science ®Google Scholar
• Kojima T, Tanaka T, and Mori H: Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 54, 1446–1449, 1994.
   PubMed Web of Science ®Google Scholar
• Chen I, Safe S, and Bjeldanes L: Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem Pharmacol 51, 1069–1076, 1996.
   PubMed Web of Science ®Google Scholar
• Bradlow HL, Telang NT, Sepkovic DW, and Osborne MP: 2-hydroxyestrone: the ‘good’ estrogen. J Endocrinol 150, 259S–265S, 1996.
   PubMed Web of Science ®Google Scholar
• Jellinck PH, Forkert PG, Riddick DS, Okey AB, Michnovicz JJ, et al.: Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol 45, 1129–1136, 1993.
   PubMed Web of Science ®Google Scholar
• Denison MS, and Nagy SR: Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43, 309–334, 2003.
   PubMed Web of Science ®Google Scholar
• Liu H, Wormke M, Safe SH, and Bjeldanes LF: Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. J Natl Cancer Inst 86, 1758–1765, 1994.
   PubMed Web of Science ®Google Scholar
• Auborn KJ, Fan S, Rosen EM, Goodwin L, Chandraskaren A, et al.: Indole-3-carbinol is a negative regulator of estrogen. J Nutr 133, 2470S–2475S, 2003.
   Web of Science ®Google Scholar
• Nelson NJ: Migrant studies aid the search for factors linked to breast cancer risk. J Natl Cancer Inst 98, 436–438, 2006.
   PubMed Web of Science ®Google Scholar
• Kusznierewicz B, Śmiechowska A, Bartoszek A, and Namieślnik J: The effect of heating and fermenting on antioxidant properties of white cabbage. Food Chem 108, 853–861, 2008.
   PubMed Web of Science ®Google Scholar
• Krajka-Kuźniak V, Szaefer H, Bartoszek A, and Baer-Dubowska W: Modulation of rat hepatic and kidney phase II enzymes by cabbage juices: comparison with the effects of indole-3-carbinol and phenethyl isothiocyanate. Br J Nutr 105, 816–826, 2011.
   PubMed Web of Science ®Google Scholar
• Licznerska BE, Szaefer H, Murias M, Bartoszek A, and Baer-Dubowska W: Modulation of CYP19 expression by cabbage juices and their active components: indole-3-carbinol and 3,3′-diindolylmethane in human breast epithelial cell lines. Eur J Nutr 52, 1483–1492, 2013.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosenbrough NJ, Farr AL, and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265–275, 1951.
   PubMed Web of Science ®Google Scholar
• Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685, 1970.
   PubMed Web of Science ®Google Scholar
• Towbin H, Staehelin T, and Gordon J: Electrophoretic transfer of proteins from polyarylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76, 4350–4354, 1979.
   PubMed Web of Science ®Google Scholar
• Howells LM, Moiseeva EP, Neal CP, Foreman BE, Andreadi CK, et al.: Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol Sin 28, 1274–1304, 2007.
   PubMed Web of Science ®Google Scholar
• Moiseeva EP, Almeida GM, Jones GDD, and Manson MM: Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol Cancer Ther 6, 3071–3079, 2007.
   PubMed Web of Science ®Google Scholar
• Oleaga C, García M, Solé A, Ciudad CJ, Izquierdo-Pulido M, et al.: CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extract. Eur J Nutr 51, 465–476, 2012.
   PubMed Web of Science ®Google Scholar
• Vogel C, and Marcotte EM: Insights into the regulation of protein abundance from proteomic and transcriptiomic analyses. Nat Rev Genet 13, 227–232, 2012.
   PubMed Web of Science ®Google Scholar
• Staub RE, Feng C, Onisko B, Bailey GS, Firestone GL, et al.: Fate of indole-3-carbinol in cultured human breast tumor cells. Chem Res Toxicol 15, 101–109, 2002.
   PubMed Web of Science ®Google Scholar
• Sissung TM, Price DK, Sparreboom A, and Figg WD: Pharmacogenetics and regulation of human cytochrome P450 1B1: implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention. Mol Cancer Res 4, 135–150, 2006.
   PubMed Web of Science ®Google Scholar
• McFadyen MCE, Rooney PH, Melvin WT, and Murray GI: Quantitative analysis of the Ah receptor/cytochrome P450 CYP1B1/CYP1A1 signalling pathway. Biochem Pharmacol 65, 1663–1674, 2003.
   PubMed Web of Science ®Google Scholar
• Bandiera S, Weidlich S, Harth V, Broede P, Ko J, et al.: Proteasomal degradation of human cytochrome P450 1B1 (CYP1B1): effect of the Asn453Ser polymorphism on the post-translational regulation of CYP1B1 expression. Mol Pharmacol 67, 435–443, 2005.
   PubMed Web of Science ®Google Scholar
• Marconett CN, Sundar SN, Poindexter KM, Stueve TR, Bjeldanes LF, et al.: Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER) alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop. Mol Biol Cell 21, 1166–1177, 2010.
   PubMed Web of Science ®Google Scholar
• Ciska E, and Pathak DR: Glucosinolate derivatives in stored fermented cabbage. J Agric Food Chem 52, 7938–7943, 2004.
   PubMed Web of Science ®Google Scholar
• Wagner AE, and Rimbach G: Ascorbigen: chemistry, occurrence, and biologic properties. Clin Dermatol 27, 217–224, 2009.
   PubMed Web of Science ®Google Scholar
• Kravchenco LV, Avren'eva LI, Guseva GV, Posdnyakov AL, and Tutel'yan VA: Effect of nutritional indoles on activity of xenobiotic metabolism enzymes and T-2 toxicity in rats. Bull Exp Biol Med 131, 544–547, 2001.
   PubMed Web of Science ®Google Scholar
• Yager JD, and Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med 354, 270–282, 2006.
   PubMed Web of Science ®Google Scholar
• Yue W, Santen RJ, Wang JP, Li Y, Verderame MF, et al.: Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 86, 477–486, 2003.
   PubMed Web of Science ®Google Scholar
• Montano MM, Chaplin LJ, Deng H, Mesia-Vela S, Gaikwad N, et al.: Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis. Oncogene 26, 3587–3590, 2007.
   PubMed Web of Science ®Google Scholar
• Bianco NR, Perry G, Smith MA, Templeton DJ, and Montano MM: Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage. Mol Endocrinol 17, 1344–1355, 2003.
   PubMed Web of Science ®Google Scholar
• Fagerholm R, Hofstetter B, Tommiska J, Aaltonen K, Vrtel R, et al.: NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nat Genet 40, 844–853, 2008.
   PubMed Web of Science ®Google Scholar
• Saw CL, Cintrón M, Wu TY, Guo Y, Huang Y, et al.: Pharmacodynamics of dietary phytochemical indoles I3C and DIM: Induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates. Biopharm Drug Dispos 32, 289–300, 2011.
   PubMed Web of Science ®Google Scholar
• Parl FF, Dawling S, Roodi N, and Crooke PS: Estrogen metabolism and breast cancer: a risk model. Ann N Y Acad Sci 1155, 68–75, 2009.
   PubMed Web of Science ®Google Scholar